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and Risk of Incident Hypertension in Women
Thomas S. Bowman, MD, MPH,*† J. Michael Gaziano, MD, MPH,*†‡ Julie E. Buring, SCD,†‡§¶
Howard D. Sesso, SCD, MPH†‡§
Boston, Massachusetts
Objectives We undertook this study to prospectively evaluate whether cigarette smoking was associated with an increased
risk of developing hypertension.
Background Smoking is a well-recognized risk factor for cardiovascular disease. Few prospective cohort studies have exam-
ined the relationship between smoking and hypertension.
Methods We conducted a prospective cohort study among 28,236 women in the Women’s Health Study who were initially
free of hypertension, cardiovascular disease, and cancer. Detailed risk factor information, including smoking sta-
tus, was collected from self-reported questionnaires. We used Cox proportional hazards survival models to calcu-
late hazard ratios (HRs) and 95% confidence intervals (CIs) of incident hypertension (defined as either new diag-
nosis, the initiation of antihypertensive medication, systolic blood pressure 140 mm Hg or diastolic blood
pressure 90 mm Hg).
Results At baseline, 51% of women were never smokers, 36% were former smokers, 5% smoked 1 to 14 cigarettes, and
8% smoked 15 cigarettes per day. During a median of 9.8 years, there were 8,571 (30.4%) cases of incident
hypertension. The age-adjusted HRs of developing hypertension among never, former, and current smokers of 1
to 14 and 15 cigarettes per day were 1.00 (reference), 1.04 (95% CI 0.99 to 1.09), 1.00 (95% CI 0.90 to
1.10), and 1.10 (95% CI 1.01 to 1.19), respectively. In multivariable models further adjusting for lifestyle, clini-
cal, and dietary variables, the corresponding HRs were 1.00 (reference), 1.03 (95% CI 0.98 to 1.08), 1.02 (95%
CI 0.92 to 1.13), and 1.11 (95% CI 1.03 to 1.21), respectively. Among women who smoked 25 cigarettes per
day, the multivariable HR was 1.21 (95% CI 1.06 to 1.39).
Conclusions In this large cohort of women, cigarette smoking was modestly associated with an increased risk of developing
hypertension, with an effect that was strongest among women smoking at least 15 cigarettes per day. (J Am
Coll Cardiol 2007;50:2085–92) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.08.017(
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cypertension is a common, chronic condition, and an
mproved understanding of its etiology could lead to new
revention and treatment efforts (1,2). Although cigarette
moking is a strong risk factor for cardiovascular disease
CVD) (3), its relationship with hypertension remains
nclear (4). Cigarette smoking causes sympathetic activa-
ion, oxidative stress, and acute vasopressor effects (5) that
re associated with increases in markers of inflammation
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ccepted August 20, 2007.6,7) that are linked with hypertension (8). Chronic smok-
ng may also lead to endothelial dysfunction (9), vascular
njury, plaque progression (10), and increased arterial stiff-
ess (11) that leads to the development of hypertension
12). The long-term effect of cigarette smoking on hyper-
ension has not been fully elucidated, and abstinence from
moking is not included in current clinical guidelines for the
revention of hypertension (13).
A recent population-based study of middle-aged men
eported that current cigarette smoking was independently
ssociated with an elevated risk of developing hypertension
14). However, other studies have reported lower blood
ressure (BP) levels among smokers (15) and increases in
P after smoking cessation (16). As a result, it remains
nclear to what extent cigarette smoking is a risk factor for
he development of hypertension (4). Therefore, we
onducted a prospective cohort study among 28,236
iddle-aged and older women initially free of hyperten-
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Smoking and Hypertension in Women November 20, 2007:2085–92sion from the Women’s Health
Study (WHS) for the association
between baseline smoking status
and risk of incident hypertension.
Methods
Study population. We analyzed
data from the WHS, a random-
ized 2  2 factorial trial of low-
dose aspirin, beta-carotene, and
vitamin E in the primary preven-
tion of cardiovascular disease and
cancer. Between September 1992
and May 1995, letters of invita-
tion and baseline health ques-
tionnaires were sent to more than
1.7 million female health profes-
ionals in the U.S. The eligibility criteria included age 45
ears and no history of coronary heart disease, cerebrovas-
ular disease, cancer (except nonmelanoma skin cancer),
r other major illness. Additional criteria consisted of no
urrent aspirin or nonsteroidal anti-inflammatory medi-
ation use more than once a week, and no current
nticoagulants or corticosteroids. A total of 453,787
omen completed the questionnaires, and 65,169 were
illing and able to participate. These women began a
-month run-in period, and a total of 39,876 women who
emained willing, eligible, and compliant were subse-
uently enrolled in the trial, which had morbidity and
ortality follow-up rates of 97.2% and 99.4%, respec-
ively (17–20). All participants gave written, informed
onsent, and the study was approved by the Institutional
eview Board of the Brigham and Women’s Hospital in
oston, Massachusetts.
Baseline information was self-reported by mailed ques-
ionnaire for demographic, lifestyle, and medical history
nformation. Every 12 months, participants were mailed
ollow-up questionnaires to evaluate compliance, side ef-
ects, clinical end points, and risk factors. For our analysis,
he baseline study population was restricted to women with
o self-reported prebaseline or baseline diagnosis of hyper-
ension, no prebaseline or baseline antihypertensive treat-
ent, a systolic blood pressure (SBP) 140 mm Hg, and a
iastolic blood pressure (DBP) 90 mm Hg. As a result of
hese exclusions, we followed 28,236 women for the devel-
pment of incident hypertension.
Body mass index (BMI) at baseline was calculated as
eight in kilograms divided by the square of height in
eters. Participants provided information on BP from 9
rdinal SBP categories ranging from 110 to 180 mm
g, and from 7 ordinal DBP categories ranging from 65
o105 mm Hg. Among health professionals, self-reported
P is greatly correlated with measured SBP (r  0.72) and
Abbreviations
and Acronyms
BMI  body mass index
BP  blood pressure
CI  confidence interval
CVD  cardiovascular
disease
DBP  diastolic blood
pressure
HR  hazard ratio
MI  myocardial infarction
SBP  systolic blood
pressure
WHO  World Health
OrganizationBP (r  0.60) (21). yscertainment of cigarette smoking status and other
ovariates. Cigarette smoking status was provided on the
aseline questionnaire. Participants were asked to classify
hemselves as never smokers (100 cigarettes in a lifetime),
ormer smokers, or current smokers. Former smokers re-
orted whether they quit within the last year. Current
mokers were categorized into 6 groups based upon number
f cigarettes smoked per day (1 to 4, 5 to 14, 15 to 24, 25
o 35, 36 to 44, or 45 cigarettes/day). Self-reported
moking status among health care professionals has been
hown to be accurate in a previous meta-analysis (22) and in
subsequent population-based study (23,24). Baseline self-
eported risk factors included age, height, weight, history of
igh cholesterol or diabetes, exercise level, alcohol use, and
arental history of myocardial infarction (MI) before the age
f 60 years. A self-administered semiquantitative food
requency questionnaire (25) also was provided by partici-
ants and included information on dietary intake of fruits
nd vegetables (26) and individual energy-adjusted dietary
actors, such as saturated fat, sodium, and potassium (27).
valuation of incident hypertension. Incident cases of
ypertension were defined by meeting at least 1 of the
ollowing 4 criteria provided by self-reports: 1) a new physician
iagnosis of hypertension on questionnaires at years 1 and 3
nd then annually thereafter; 2) starting antihypertensive
reatment during follow-up; 3) SBP 140 mm Hg during
ollow-up; or 4) DBP 90 mm Hg during follow-up (8).
articipants reporting a new hypertension diagnosis also
ere asked to provide the month and year that it occurred.
ny missing date for incident hypertension was assigned a
ate by randomly selecting a date between the current and
revious annual questionnaire. All participants were fol-
owed for CVD events, and all relevant medical information
as reviewed by the WHS Endpoints Committee com-
osed of physicians (19). Participants who developed a
VD event (including MI, stroke and revascularization)
hat may have affected their BP or BP management were
ensored at the date of diagnosis and not considered an
ncident case of hypertension.
tatistical analysis. We first divided the baseline popula-
ion into 4 groups based upon cigarette smoking status
never, past, currently smoking 15 cigarettes per day, and
urrently smoking 15 cigarettes per day) and computed
eans or proportions of baseline variables for each group
nd for the entire cohort. Categories were compared using
nalysis of variance or chi-square tests. We determined the
umber of incident hypertension cases and calculated
ollow-up time in person-years. To determine the effect of
igher levels of smoking, we also evaluated participants who
moked 15 to 24, 25, and 45 cigarettes/day.
We used Cox proportional hazards survival models to
alculate the hazard ratios (HRs) and 95% confidence
ntervals (CIs) for risk of incident hypertension, using never
mokers as the reference group. The crude model included
nly smoking status. We then adjusted for baseline age (in
ears). The multivariable model additionally adjusted for
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to 3 per week, 4 per week), alcohol use (rarely/never, 1
o 3 per month, 1 to 6 per week, 1 per day), history of
iabetes, history of high cholesterol 240 mg/dl or use of
holesterol-lowering medication, and energy-adjusted di-
tary intake of fruits and vegetables (servings/day), saturated
at (g/day), sodium (mg/day), and potassium (mg/day).
or exercise level and alcohol use, we did not take into
ccount their ordinality because there is no established
raded relationship between these variables and risk of
ypertension. Because our variable for parental history of
I before age 60 years (yes/no) had missing data in 9.7%
f participants, we included those missing this informa-
ion with an indicator variable in our multivariable
odels. In supplementary analyses, we assessed the effect
f including both SBP and DBP category in the multi-
ariable model.
Because the relationship between smoking status and
ypertension may be affected by body weight, we stratified
ur population by baseline BMI using World Health
rganization (WHO) criteria and evaluated the risk of
ypertension among normal (18.5 to 25 kg/m2), over-
eight (25 to 30 kg/m2), and obese (30 kg/m2) partic-
pants (28). A test for interaction between smoking status,
MI category, and the risk of developing hypertension was
ssessed where both smoking status and WHO category
ere ordinal variables.
We also stratified the cohort according to baseline SBP
nd DBP levels to determine whether smoking has differ-
ntial effects on the risk of developing hypertension based
pon initial BP level. The test for interaction was assessed
or baseline smoking status and SBP and DBP category
sing ordinal variables. All HRs are presented with 95%
Is, and all reported p values are 2-sided. All data
nalyses were performed using SAS version 9.1 (SAS
nstitute, Cary, North Carolina).
esults
mong the 28,236 women in our study, the mean (SD)
ge at baseline was 53.7  6.6 years, and 13.3% of
articipants were current smokers (Table 1). The mean
SD) BMI was 25.2  4.5 kg/m2, with 30% of partici-
ants classified as overweight and 13% as obese. When we
tratified the cohort by smoking status, there were 14,377
ever smokers, 10,115 former smokers, 1,409 participants
ho currently smoked 1 to 14 cigarettes/day, and 2,335
articipants who currently smoked 15 cigarettes per day.
urrent smokers had slightly greater levels of baseline SBP
p  0.01) and DBP (p  0.05). Current smokers had a
ower average BMI, greater intake of saturated fat, exercised
ess, and were more likely to drink alcohol (all p  0.01).
fter a median follow-up of 9.8 years, (228,933 person-
ears), there were 8,571 cases of incident hypertension
efined by medical diagnosis (36.7%), elevations in BP s20.6%), initiation of antihypertensive treatment (3.1%), or
combination of the aforementioned (39.2%).
In Cox proportional hazard survival models using never
mokers as the reference group, former smokers had an
ge-adjusted HR of 1.04 (95% CI 0.99 to 1.09) and
ultivariable-adjusted HR of 1.03 (95% CI 0.98 to 1.08)
Table 2). Participants who smoked 1 to 14 cigarettes/day
ad an age-adjusted HR of 1.00 (95% CI 0.90 to 1.10) and
ultivariable-adjusted HR of 1.02 (95% CI 0.92 to 1.13),
hereas those who smoked 15 cigarettes/day had an
ge-adjusted HR of 1.10 (95% CI 1.01 to 1.19) and
ultivariable-adjusted HR of 1.11 (95% CI 1.03 to 1.21).
hen we considered the addition of randomized aspirin,
eta-carotene, and vitamin E treatment to our multiva-
iable models, the HRs for smoking status remained
nchanged. We then evaluated the 702 women who
urrently smoked 25 cigarettes/day and the 53 women
ho smoked 45 cigarettes/day, and the age-adjusted
Rs were 1.22 (95% CI 1.07 to 1.39) and 1.26 (95% CI
.81 to 1.98), whereas the multivariable-adjusted HRs
ere 1.21 (95% CI 1.06 to 1.39) and 1.16 (95% CI 0.74
o 1.82), respectively.
We next considered the additional adjustment by baseline
BP or DBP in our multivariable models, which only
lightly affected the multivariable HRs. For example, former
mokers and those currently smoking 1 to 14 cigarettes/day
ad a slight increase in their HRs of hypertension, whereas
he HRs among women smoking 15 cigarettes/day did
ot materially change.
When we stratified the cohort by baseline WHO cate-
ory, participants with a normal BMI (18.5 to 25 kg/m2)
ad the greatest HRs of developing hypertension (p inter-
ction  0.04) (Table 3). Among these participants, the
ultivariable HRs for former smokers and those currently
moking 1 to 14 cigarettes/day and 15 cigarettes/day were
.04, 1.11, and 1.21, respectively. Among women in the
ormal weight category who were currently smoking
25 cigarettes/day, the multivariable HR was 1.31 (95%
I 1.07 to 1.61). Among participants in the overweight (25
o30 kg/m2) and obese (30 kg/m2) categories, there was
o statistical association between cigarette smoking and
ypertension.
We next stratified the cohort by baseline SBP and DBP
ategory and evaluated smoking status and the risk of devel-
ping hypertension (Table 4). In age-adjusted and
ultivariable-adjusted models, the highest HRs were
mong those patients with a lower baseline BP. Former and
urrent smokers with an initial DBP 75 mm Hg were at
greater relative risk of developing hypertension compared
ith those with a DBP that was75 mm Hg (p interaction
0.01). Former and current smokers with a SBP120 mm
g also had greater HRs compared with those with a SBP
120 mm Hg, but this finding did not reach statisticalignificance (p interaction0.13).
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n this large prospective cohort study of 28,236 women
nitially free of hypertension and followed for a median of
.8 years, we found a significantly increased risk of devel-
ping hypertension among women currently smoking at
east 15 cigarettes per day. The magnitude of effect from
igarette smoking was modest, and an increased risk of
ypertension was most pronounced among women with a
ormal BMI or low initial BP.
In the U.S., 21% of adults (44.5 million individuals) were
urrent smokers in 2004, despite a national health objective
o reduce the prevalence of smoking to 12% by 2010 (29).
mong U.S. women in 2004, 18.5% were current smokers
29), a proportion similar to our study cohort in whom
Baseline Characteristics of 28,236 Women,According to Bas l ne Cigarette Smoking Statu
Table 1 Baseline Characteristics of 28,236According to Baseline Cigarette Sm
Characteristic Never
n 14,337
Age, yrs* 53.6 (6.7)
BMI, kg/m2* 25.2 (4.5)
WHO category*
Normal 56.1
Overweight 29.3
Obese 13.4
Physical activity, %*
Rarely/never 34.5
1 per week 20.4
1–3 per week 33.6
4 per week 11.5
Alcohol use, %*
Rarely/never 50.7
1–3 drinks/month 13.6
1–6 drinks/week 29.6
1 drink/day 6.1
Parental history of MI before
age 60 yrs, %*
11.9
Diabetes, % 1.3
History of hyperlipidemia, % 24.2
Fruit and vegetables, servings/day* 6.2 3.6
Dietary saturated fat, g/day* 19.3 4.6 1
Dietary sodium, g/day* 1.86 0.33 1
Dietary potassium, g/day* 3.20 0.58 3
SBP, mm Hg*
110 20.3
110–119 37.2
120–129 29.4
130–139 13.1
DBP, mm Hg†
65 11.7
65–74 40.9
75–84 39.2
85–89 8.2
Values are mean  SD. *p  0.01. †p  0.05.
BMI  body mass index; DBP  diastolic blood pressure; MI  m
Organization.5.3% of women were current smokers at baseline in 1992. aurrently, there are at least 65 million people with hyper-
ension in the U.S. (30), and the lifetime risk of developing
ypertension is estimated at 90% (31). In our cohort, 30.2%
f women became hypertensive over 10 years, a rate similar
o that among 379 men followed for 11 years where 32.7%
eveloped hypertension (14).
Although cigarette smoking has many well-established
etrimental health effects (32), smoking has variable effects
n BP. For example, quitting smoking decreases inflamma-
ion (6) but may also lead to weight gain (14) that causes
reater BPs and increased rates of hypertension (33,34).
moking also may reduce weight gain and affect the relation-
hip between smoking and hypertension among overweight
nd obese women. Although the HRs of hypertension
en,
g Status
Cigarette Smoking Status
t 1–14/day >15/day Total
5 1,409 2,335 28,236
.5) 53.6 (6.3) 53.2 (6.1) 53.7 (6.6)
.4) 24.7 (4.4) 24.9 (4.5) 25.2 (4.5)
61.0 56.8 56.2
25.3 29.1 29.5
11.9 12.0 13.1
42.5 54.4 36.0
22.3 23.2 20.2
28.9 19.2 32.6
6.3 3.1 11.3
40.0 44.2 42.9
12.3 13.2 13.4
33.9 27.9 33.4
13.8 14.8 10.3
14.6 14.6 12.4
1.0 1.7 1.3
23.1 26.2 24.6
3.6 5.6 3.5 4.9 3.1 6.1 3.6
4.7 20.7 4.9 22.3 5.4 19.6 4.8
0.34 1.85 0.35 1.90 0.38 1.87 0.34
0.58 3.18 0.62 3.12 0.63 3.21 0.59
21.5 20.5 20.3
41.0 35.6 37.6
25.6 29.5 28.8
11.9 14.5 13.3
13.8 12.3 12.0
44.1 40.7 41.1
34.9 39.0 38.8
7.2 8.0 8.1
ial infarction; SBP  systolic blood pressure; WHO  World Healths
Wom
okin
Pas
10,11
54.1 (6
25.3 (4
55.5
30.5
13.0
32.8
18.9
34.7
13.5
31.8
13.3
40.1
14.8
12.5
1.3
25.1
6.2
9.2
.87
.25
20.2
38.0
28.2
13.6
12.3
40.9
38.7
8.2mong women currently smoking 1 to 14 cigarettes/day did
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stimates were1.0 and consistent with a slightly increased
isk of hypertension.
Inflammation also may mediate the relationship between
moking and high BP. In a nationally representative sample,
igarette smoking was associated with elevated inflam-
atory biomarkers and chronic systemic inflammation
7). In the WHS, both former and current smokers had
ncreased levels of inflammatory biomarkers (35), and
igher baseline levels of C-reactive protein have been
ssociated with an increased risk of subsequent hyperten-
ion (8). In a large population-based study in England,
he independent association between smoking and BP
as small, but causality could not be addressed in this
ross-sectional study (36). A prospective study among
iddle-aged men in Finland supported the idea that
moking may be a risk factor for hypertension, however
azard Ratios (95% Confidence Intervals) From Cox Proportional Hf Incident Hypertensi , According to Baseline Cigarette Smoking
Table 2 Hazard Ratios (95% Confidence Intervals) From Cox Prof Incident Hypertension, According to Baseline Cigare
Baseline Smoking Status
Never Former 1 to
n 14,377 10,115
Person-yrs 117,020 81,898 1
Cases 4,273 3,150
Crude 1.00 (ref) 1.06 (1.01–1.11) 0.99 (
Age-adjusted 1.00 (ref) 1.04 (0.99–1.09) 1.00 (
Multivariable* 1.00 (ref) 1.03 (0.98–1.08) 1.02 (
Multivariablesystolic and
diastolic blood pressure
1.00 (ref) 1.05 (1.00–1.10) 1.09 (
Adjusted for age, body mass index, exercise level, alcohol use, parental history of myocardial infa
ntake of energy-adjusted dietary factors (fruits and vegetables, saturated fat, sodium, and pota
itamin E) in the multivariable model did not change the hazard ratios for smoking status.
Hazard Ratios (95% Confidence Intervals) FromModels of Incident Hypert sion According toAmong 28,236 Par icipants, Stratified by Basel
Table 3
Hazard Ratios (95% Confidence Inte
Models of Incident Hypertension A
Among 28,236 Participants, Stratifi
WHO category Never
Normal (18.5 to 25.0 kg/m2)
n 8,058
Cases 1,806
Age-adjusted 1.00 (ref) 1.06
Multivariable* 1.00 (ref) 1.04
Overweight (25.0 to 30.0 kg/m2)
n 4,213
Cases 1,522
Age-adjusted 1.00 (ref) 1.02
Multivariable* 1.00 (ref) 1.03
Obese (30 kg/m2)
n 1,927
Cases 916
Age-adjusted 1.00 (ref) 1.00
Multivariable* 1.00 (ref) 0.99
*Adjusted for age, body mass index, exercise level, alcohol use, pare
cholesterol (self-reported history or current treatment), and intake of e
and potassium).
WHO  World Health Organization.he study size was small (n  379) and requires confir-
ation in other cohorts (14).
There are several other potential biological mechanisms
hrough which exposure to cigarette smoke may lead to high
P. Long-term smoking leads to abnormalities of myocar-
ial blood flow, which may be due to impairment of the
ascular endothelium (37). Cigarette smoking also in-
reases BP by stiffening arteries, with particularly dele-
erious effects on chronic smokers (38). Smoking in youth
s associated with arterial changes and increased common
arotid artery intima-media thickness in adulthood (39).
moking in adults is also associated with progression of
therosclerosis, and these adverse effects may be cumu-
ative and irreversible (40).
tudy limitations. Our study has several strengths, includ-
ng the prospective collection of data, large number of
articipants and events, and long follow-up. Some potential
s Survival Modelsus Among 28,236 Participants
ional Hazards Survival Models
moking Status Among 28,236 Participants
Higher Categories
ay >15/day 15 to 24/day >25/day
2,335 1,633 702
18,491 13,120 5,371
731 493 238
1.10) 1.08 (1.00–1.17) 1.03 (0.94–1.13) 1.20 (1.06–1.37)
1.10) 1.10 (1.01–1.19) 1.05 (0.95–1.15) 1.22 (1.07–1.39)
1.13) 1.11 (1.03–1.21) 1.07 (0.97–1.18) 1.21 (1.06–1.39)
1.21) 1.11 (1.02–1.20) 1.08 (0.98–1.18) 1.18 (1.03–1.35)
efore age 60 years, diabetes and high cholesterol (self-reported history or current treatment), and
. Note: The further consideration of randomized treatment assignment (aspirin, beta-carotene,
Proportional Hazards Survivalline Cigarette Smoking StatusHO ategory
) From Cox Proportional Hazards Survival
ing to Baseline Cigarette Smoking Status
y Baseline WHO Category
r Current, 1 to 14/day Current, >15/day
6 860 1,326
3 219 345
–1.14) 1.14 (0.99–1.31) 1.23 (1.09–1.38)
–1.12) 1.11 (0.96–1.28) 1.21 (1.07–1.36)
8 357 679
9 121 235
–1.11) 0.96 (0.80–1.16) 1.00 (0.87–1.15)
–1.12) 0.97 (0.80–1.17) 0.99 (0.86–1.14)
3 167 281
7 70 141
–1.11) 0.88 (0.69–1.12) 1.10 (0.92–1.31)
–1.11) 0.86 (0.67–1.11) 1.13 (0.94–1.36)
tory of myocardial infarction before age 60 years, diabetes and high
djusted dietary factors (fruits and vegetables, saturated fat, sodium,azardStat
oport
tte S
14/d
1,409
1,523
417
0.90–
0.90–
0.92–
0.98–
rction bCoxBaseine W
rvals
ccord
ed b
Forme
5,61
1,35
(0.99
(0.97
3,08
1,14
(0.95
(0.95
1,31
62
(0.90
(0.89
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Smoking and Hypertension in Women November 20, 2007:2085–92imitations include self-reported smoking status; however,
oth a population-based study (23,24) and a meta-analysis
sing serum cotinine have confirmed that self-reports of
moking are accurate (22), and self-reported medical infor-
ation from health professionals is reliable (41). For self-
eported hypertension in the WHS, there is an 86%
alidation rate, which is consistent with other studies
41,42), and any potential misclassification would be ran-
Hazard Ratios (95% Confidence Intervals) FromModels of Incident Hypert sion According toAmong 28,236 Par icipants, Stratified by Basel
Table 4
Hazard Ratios (95% Confidence Inte
Models of Incident Hypertension A
Among 28,236 Participants, Stratifi
Never Form
SBP category (mm Hg)
110
n 2,914 2,04
No. cases 288 21
Age-adjusted 1.00 (ref) 1.06 (0.8
Multivariable* 1.00 (ref) 1.11 (0.9
110–119
n 5,354 3,84
No. cases 1,075 83
Age-adjusted 1.00 (ref) 1.09 (0.9
Multivariable* 1.00 (ref) 1.05 (0.9
120–129
n 4,227 2,85
No. cases 1,653 1,17
Age-adjusted 1.00 (ref) 1.07 (0.9
Multivariable* 1.00 (ref) 1.09 (1.0
130–139
n 1,882 1,37
No. cases 1,257 92
Age-adjusted 1.00 (ref) 0.99 (0.9
Multivariable* 1.00 (ref) 0.99 (0.9
DBP category (mm Hg)
65
n 1,679 1,24
No. cases 171 12
Age-adjusted 1.00 (ref) 0.97 (0.7
Multivariable* 1.00 (ref) 1.06 (0.8
65–74
n 5,885 4,13
No. cases 1,150 93
Age-adjusted 1.00 (ref) 1.16 (1.0
Multivariable* 1.00 (ref) 1.14 (1.0
75–84
n 5,634 3,90
No. cases 2,188 1,56
Age-adjusted 1.00 (ref) 1.03 (0.9
Multivariable* 1.00 (ref) 1.02 (0.9
85–89
n 1,179 82
No. cases 764 52
Age-adjusted 1.00 (ref) 0.97 (0.8
Multivariable* 1.00 (ref) 0.97 (0.8
*Adjusted for age, body mass index, exercise level, alcohol use, pare
cholesterol (self-reported history or current treatment), and intake of e
and potassium).
DBP  diastolic blood pressure; SBP  systolic blood pressure.om and likely bias our HRs to the null. Our participants mere all apparently healthy female health professionals,
ossibly affecting this study’s generalizability to other
opulations; however, we have no reason to believe that
he biological mechanisms by which chronic cigarette
moking may be associated with developing hypertension
s unique to our study population (7,14). In the WHS,
oss to follow-up was minimal regardless of smoking
tatus and should not appreciably affect our risk esti-
Proportional Hazards Survivalline Cigarette Smoking StatusBP and DBP
) From Cox Proportional Hazards Survival
ing to Baseline Cigarette Smoking Status
y Baseline SBP and DBP
Current, 1 to 14/day Current, >15/day
303 478
38 49
) 1.29 (0.92–1.80) 1.03 (0.76–1.39)
) 1.33 (0.94–1.88) 1.06 (0.77–1.46)
577 830
137 185
) 1.21 (1.01–1.44) 1.15 (0.99–1.35)
) 1.18 (0.98–1.42) 1.15 (0.98–1.36)
361 688
129 279
) 0.89 (0.75–1.07) 1.07 (0.95–1.22)
) 0.92 (0.77–1.11) 1.09 (0.95–1.24)
168 339
113 218
) 1.01 (0.83–1.22) 0.99 (0.85–1.14)
) 1.05 (0.86–1.28) 1.03 (0.89–1.20)
194 286
37 37
) 1.98 (1.39–2.83) 1.30 (0.91–1.85)
) 2.00 (1.38–2.90) 1.23 (0.84–1.80)
622 951
116 213
) 0.96 (0.79–1.16) 1.22 (1.05–1.41)
) 0.96 (0.79–1.17) 1.27 (1.09–1.48)
492 911
201 369
) 1.06 (0.92–1.23) 1.08 (0.97–1.21)
) 1.10 (0.95–1.28) 1.10 (0.98–1.24)
101 187
63 112
) 0.92 (0.71–1.18) 0.91 (0.74–1.11)
) 0.94 (0.72–1.23) 1.01 (0.82–1.24)
tory of myocardial infarction before age 60 years, diabetes and high
djusted dietary factors (fruits and vegetables, saturated fat, sodium,CoxBaseine S
rvals
ccord
ed b
er
1
8
9–1.26
2–1.34
6
4
9–1.19
6–1.16
3
8
9–1.15
1–1.18
5
0
1–1.08
1–1.09
2
7
7–1.22
3–1.35
5
1
6–1.26
4–1.25
9
7
6–1.10
6–1.10
9
5
6–1.08
6–1.09
ntal his
nergy-aates. We adjusted for many potential confounders in
o
f
g
c
w
C
A
9
f
r
t
i
t
h
m
B
c
g
h
p
v
o
A
W
c
m
R
D
o
p
R
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
2091JACC Vol. 50, No. 21, 2007 Bowman et al.
November 20, 2007:2085–92 Smoking and Hypertension in Womenur multivariable models and although residual con-
ounding may be present in this observational study,
iven the relatively small impact of adjusting for other
onfounders, we believe that any residual confounding
ould only marginally impact the HRs.
onclusions
mong apparently healthy women followed for a median of
.8 years, an increased risk of developing hypertension was
ound among women currently smoking at least 15 ciga-
ettes per day. Whether the magnitude of effect is suscep-
ible to confounding or reflects a true association requires an
mproved understanding of the biological mechanisms
hrough which smoking may lead to the development of
ypertension.
Although the risk estimates were modest and found
ainly among women with a normal BMI and lower initial
Ps, the population-attributable risk of hypertension asso-
iated with cigarette smoking may potentially be substantial
iven the high prevalence of hypertension. Therefore, public
ealth efforts to reduce the burden of smoking remain a
otentially clinically relevant and effective strategy for pre-
enting hypertension and reducing the impact of smoking
n CVD.
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